Randomized, Open-labeled, Single Dosing Study to Assess Food Effect on the Pharmacokinetics of Hemay005 in Healthy Volunteers
Latest Information Update: 19 Jan 2026
At a glance
- Drugs Mufemilast (Primary)
- Indications Psoriasis
- Focus Pharmacokinetics
- Sponsors Tianjin Hemay Biotech
Most Recent Events
- 30 Mar 2021 Status changed from not yet recruiting to completed.
- 11 Jul 2018 New trial record